Latest News

£12 million investment for Oxford University Innovation spin-out Nightstar

30th January 2014

All News | Financial News | Spinouts & Startups | Technology News

Wellcome Trust's VC arm backs an Isis spinout developing a gene therapy for inherited blindness.

Immunotec Oxford Raises $64m in Nasdaq IPO

25th November 2013

All News | Financial News | Spinouts & Startups | Technology News

Oxford Immunotec – a 2002 Isis spin-out – has raised US$64 million in an IPO on America’s Nasdaq stock exchange. The Abingdon-based company sells diagnostic tests for latent tuberculosis infection, T-SPOT®.TB.

Immunocore Announces Multimillion Dollar Research Collaboration and Licensing Agreement

3rd July 2013

All News | Financial News | Technology News

Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs known as ImmTACs to treat cancer and viral disease, has announced that it has entered into a research collaboration and licensing agreement with Genentech, a member of the Roche Group, for the discovery and development of multiple novel cancer targets using Immunocore’s ImmTAC technology.

Oxford University Innovation Taking Part In Oxfam Trailtrekker Challenge

20th February 2013

All News | Financial News

The Challenge Trailtrekker is a 100km trek across the Yorkshire Dales National Park, non-stop throughout day and night over 30 hours. The route is challenging, requiring great determination and teamwork. Our four person Isis/Oxford team has chosen the extreme challenge to raise the most amount of money possible towards making a real difference for those living in poverty.

£30m Raised in Share Issue by Oxford Spin-out, Oxford Catalysts

4th January 2013

All News | Financial News | Spinouts & Startups

Oxford Catalysts was spun-out to produce catalysts for the generation of clean fuels by Isis in 2005 and is now valued at approx. £130m.

Spin-out OrganOx secures series C funding

9th May 2012

All News | Financial News | Spinouts & Startups | Technology News

OrganOx, a medical device development company focused on increasing the quality and supply of organs for transplantation, has completed a series C investment round of just under £1 million.

Further Investment in Energy Management Technology Spun-out of Oxford

19th April 2012

All News | Financial News | Spinouts & Startups | Technology News

Navetas Energy Management has secured £5m in strategic investment from Sensus, a leading utility infrastructure company offering smart meters and communication systems for the electric, gas, and water industries. The investment deal will see Sensus acquire a 15% stake in Navetas and an exclusive licence agreement for Navetas technology in the United States market.

Oxford Thinking Campaign Reaches £1.25 Billion Landmark

20th March 2012

All News | Financial News

The Oxford Thinking Campaign has now passed its initial target of £1.25 billion raised for the collegiate University.

Leading Healthcare Company Provides Support for Oxford Invention Fund

15th March 2012

All News | Financial News | Technology News

Oxford University Innovation is pleased to announce that the Oxford Invention Fund has accepted funding support from the Johnson & Johnson Corporate Office of Science and Technology (COSAT). This is the first industry support for the Oxford Invention Fund.

Isis Start-up Provides Sentiment Analysis Tool for Business, Finance

13th February 2012

All News | Financial News | Spinouts & Startups | Technology News

Oxford-developed software which builds on a deep understanding of linguistics to assess accurately what people mean from what they say online will provide a “sentiment analysis” tool for businesses, particularly finance companies. The new company, TheySay, has been set up by the University’s technology transfer company, Oxford University Innovation and today announced it had received first-round investment of up to £500,000 from IP Group plc.

News

Ready to get in touch?